Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance

Armstrong AW, Krueger JG, Strober BE, Stein Gold LF, Desai SR, Muscianisi E, Klyachkin Y, Ucpinar S, Tilley MK, Blauvelt A. Envudeucitinib, a Potent, Next-Generation,[...]

Wongvibulsin S, Primiero CA, Adamson AS, Barata C, Betz-Stablein B, Celebi ME, Dawant B, Guitera P, Kelly KM, Kittler H, Kose K, Landman B, Lehman[...]

Siletz AE, Kelly-Scumpia KM, Scumpia PO, Street K, Ragkousis V, Shirazi R, Sanaiha Y, Do TH, Shemin R, Kwon M, Crager S, Benharash P, Cryer[...]